Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in GTBP — GT Biopharma, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to GTBP Full portfolio

Position in GTBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,833
+$1,291 QoQ
Shares Held
639
-0.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 57 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 37% Shared 0% None 63%

Common Shares in GTBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,878 across 417 Biotechnology names. GTBP ranks #323 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in GTBP

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,833 15,986
2026-03-31 $6,542 16,037
2025-12-31 $12,588 16,037
2025-09-30 $5,877 10,012
2025-06-30 $35,842 10,012
2025-03-31 $21,527 10,013
2024-12-31 $30,539 10,013
2024-09-30 $23,120 10,013
2024-06-30 $28,336 10,013
2024-03-31 $44,405 10,024
2023-12-31 $76,682 300,719
2023-09-30 $72,467 300,697
2023-06-30 $31,383 100,594
2023-03-31 $55,307 100,562
2022-12-31 $89,094 100,560
2022-09-30 $959 546
2022-06-30 $1,763 590
2022-03-31 $87,081 30,237
2021-12-31 $32,477 10,649
2021-09-30 $11,982 1,778
2021-06-30 $6,199 400
2021-03-31 $813 119